Autonomix Medical
Jennifer Cook serves as the Chief Business Officer at Autonomix Medical since March 2024, while simultaneously holding the position of Principal and Founder at Shoreby Consulting, LLC since June 2017, focusing on healthcare and medical technology consulting. Previous roles include Vice President of Marketing at MedShift, where brand transformation efforts were spearheaded, and at Soliton, Inc., where the RESONIC™ brand was architected. Jennifer has extensive marketing experience, having led consumer marketing strategies for Apollo Endosurgery and built digital divisions at W2O Group. A proven leader in both B2C and B2B marketing, Jennifer has consistently driven growth and value across various organizations. Educational background includes a Bachelor of Science in Business Administration with a focus on Marketing from Miami University.
This person is not in any teams
Autonomix Medical
Autonomix (Nasdaq: AMIX) is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate neural signals with approximately 3,000 times greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body. We are initially developing our technology for pancreatic cancer pain, a condition that can cause debilitating pain and needs an effective solution. However, our technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation and chronic pain management across a wide disease spectrum.